What Is Rhino Tranq? Medetomidine Exposure and Withdrawal Risks
Quick answer: Rhino tranq is a street name for medetomidine, a veterinary sedative found in some illicit fentanyl mixtures. Exposure and withdrawal can cause serious medical complications, and severe symptoms require urgent assessment.
Rhino tranq is a street name for medetomidine, a potent sedative used in veterinary medicine. It is not approved for human use.
Medetomidine belongs to a class of medications called alpha-2 adrenergic agonists. These substances affect the nervous system and can reduce heart rate, blood pressure, and alertness.
When medetomidine is mixed with illicit fentanyl, a person may experience the effects of both an opioid and a powerful sedative.
Someone exposed to this combination may not know that medetomidine is present.
Is Rhino Tranq the Same as Xylazine?
No. Although medetomidine and xylazine are both veterinary sedatives, they are different substances.
Xylazine became widely discussed because of its presence in the illicit opioid supply and its association with prolonged sedation and serious skin wounds.
Medetomidine is another alpha-2 agonist with particularly concerning cardiovascular and withdrawal effects.
Both substances can complicate overdose response and withdrawal treatment, but they should not be treated as interchangeable.
Emergency warning: If someone is unresponsive or breathing abnormally, call 911 and administer naloxone if available. Naloxone can reverse an opioid overdose component but does not directly reverse medetomidine.
On This Page
Why Is Medetomidine Appearing in Fentanyl?
Illicitly manufactured drugs may contain multiple substances that were not disclosed to the person purchasing them.
Medetomidine has been detected in samples containing illegally manufactured fentanyl. Its presence can intensify sedation and make the effects of a drug mixture more difficult to predict.
According to the CDC’s April 2026 advisory, reports of medetomidine in U.S. law enforcement drug seizures increased from 247 in 2023 to 8,233 in 2025.
These figures represent forensic detections, not the number of people exposed or the percentage of fentanyl circulating in Tennessee.
Although national detections have been concentrated in the Northeast and Midwest, the Tennessee Department of Health has also confirmed medetomidine in the state’s illicit drug supply.
What Are the Symptoms of Medetomidine Exposure?
Medetomidine can suppress important functions of the nervous system.
Potential signs of intoxication include:
- Profound or prolonged sedation
- Unusually slow heart rate
- Low blood pressure
- Reduced responsiveness
- Dangerous complications when combined with opioids or other depressants
Because fentanyl may also be present, opioid overdose can occur at the same time.
Emergency warning: If someone is unconscious, breathing slowly, making gurgling sounds, or cannot be awakened, call 911 immediately. Administer naloxone if available and follow emergency dispatcher instructions.
Naloxone can reverse the opioid component of an overdose, but it does not directly reverse medetomidine. Emergency medical evaluation remains necessary even when naloxone has been administered.
What Happens During Medetomidine Withdrawal?
One of the most concerning aspects of medetomidine is the possibility of severe withdrawal following repeated exposure.
The CDC has warned that medetomidine withdrawal may cause dangerous changes in cardiovascular and nervous system function.
Reported symptoms include:
- Severe elevations in blood pressure
- Rapid heart rate
- Tremors and sweating
- Persistent nausea and vomiting
- Agitation or changes in alertness
- Chest discomfort
- Potentially life-threatening complications
These symptoms can differ significantly from typical opioid withdrawal.
While opioid withdrawal commonly causes muscle aches, gastrointestinal distress, anxiety, and restlessness, medetomidine withdrawal can involve severe cardiovascular instability.
This distinction matters because someone who believes they are experiencing ordinary fentanyl withdrawal may actually be experiencing symptoms related to multiple substances.
Has Rhino Tranq Been Found in Tennessee?
Yes.
The Tennessee Department of Health reports that medetomidine was first confirmed in small quantities in East and West Tennessee beginning in 2024.
This does not establish how common medetomidine is in Nashville, La Vergne, or Rutherford County. However, it demonstrates why Tennessee residents should be aware of emerging substances in the illicit opioid supply.
People seeking help for fentanyl dependence should tell their healthcare team about any unexpected symptoms, unusually prolonged sedation, or concerns about exposure to mixed substances.
Even when the exact contents of a substance are unknown, that information may help clinicians assess withdrawal risks.
Frequently Asked Questions
Is rhino tranq an opioid?
No. Rhino tranq refers to medetomidine, a veterinary sedative. It may be mixed with fentanyl, which is an opioid.
Can naloxone reverse rhino tranq?
How long does medetomidine withdrawal last?
There is not yet a well-established withdrawal timeline that applies to everyone. The duration and severity may depend on exposure patterns, other substances involved, and individual medical factors. Severe symptoms require medical evaluation.
Can medetomidine cause high blood pressure during withdrawal?
Yes. Severe hypertension is among the withdrawal complications described in the CDC’s 2026 health advisory.
Is medetomidine found in Tennessee?
The Tennessee Department of Health has confirmed medetomidine in the state’s illicit drug supply. Available statewide reporting does not establish the current prevalence in every Tennessee community.
Why does identifying medetomidine exposure matter?
Medetomidine is not an opioid, so opioid-specific treatment does not directly address its effects. Knowing that exposure is possible helps clinicians evaluate unusual sedation, blood-pressure changes, and withdrawal symptoms.
Questions About Unexpected Sedative Exposure in Tennessee
If you are concerned that fentanyl or another street drug contained medetomidine, describe the exposure and symptoms to a qualified healthcare professional. Severe blood-pressure changes, chest pain, confusion, or reduced responsiveness require urgent medical evaluation.
For information about opioid withdrawal services, see fentanyl detox in Tennessee. For ongoing opioid addiction treatment options, see fentanyl rehab in Tennessee. These are separate treatment resources; this article is about the emerging contaminant.
For non-emergency admissions questions, call Tennessee Detox Center at (615) 488-5311. Call 911 for a suspected overdose or medical emergency.
Clinical and Editorial Sources
Centers for Disease Control and Prevention. Medetomidine in the U.S. Illegal Fentanyl Supply Increasing Risk for Overdose and Severe Withdrawal Syndrome. April 2, 2026. https://www.cdc.gov/han/php/notices/han00527.html
Centers for Disease Control and Prevention. Medetomidine Situation Summary. April 2, 2026. https://www.cdc.gov/overdose-prevention/situation-summary/medetomidine.html
Tennessee Department of Mental Health and Substance Abuse Services. Emerging Substances. https://www.tn.gov/behavioral-health/substance-abuse-services/prevention/emerging-substances.html
Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. 2024. https://store.samhsa.gov/sites/default/files/federal-guidelines-opioid-treatment-pep24-02-011.pdf
This article is intended for educational purposes and does not replace individualized medical advice, diagnosis, or emergency treatment.
Medically Reviewed By:
Dr. Vahid Osman, M.D.Board-Certified Psychiatrist and Addictionologist
Dr. Vahid Osman is a Board-Certified Psychiatrist and Addictionologist who has extensive experience in skillfully treating patients with mental illness, chemical dependency and developmental disorders. Dr. Osman has trained in Psychiatry in France and in Austin, Texas. Read more.
Clinically Reviewed By:
Josh Sprung, L.C.S.W.Board Certified Clinical Social Worker
Joshua Sprung serves as a Clinical Reviewer at Tennessee Detox Center, bringing a wealth of expertise to ensure exceptional patient care. Read More
The Joint Commission – The Gold Seal of Approval® signifies that Tennessee Detox Center meets or exceeds rigorous performance standards in patient care, safety, and quality. It reflects a commitment to continuous improvement and clinical excellence.
LegitScript Certified – Confirms that Tennessee Detox Center operates in full compliance with laws and regulations, and meets high standards for transparency and accountability in addiction treatment marketing.
BBB Accredited – Demonstrates ethical business practices, commitment to customer satisfaction, and a trusted reputation within the community.
Psychology Today Verified – Indicates that Tennessee Detox Center is listed on Psychology Today, a trusted directory for verified mental health providers and treatment centers.
HIPAA Compliant – Ensures all patient health information (PHI) is protected and managed in accordance with strict federal privacy and data security standards.
ASAM Member – Tennessee Detox Center is a proud member of the American Society of Addiction Medicine (ASAM), reflecting a commitment to science-driven and evidence-based treatment standards.
Rutherford County Chamber of Commerce – Membership signifies active participation in the local community and support for regional growth and civic collaboration.
Get Family Support Now
Supporting Families Through Recovery
We understand addiction affects the whole family. Our comprehensive family program helps rebuild trust and restore relationships.
Weekly Family Therapy Sessions
Educational Workshops
Support Groups
Communication Skills Training
Compassionate Rehab Services
Evidence-Based Treatment
Did you know that your insurance plan may cover medical detox?
What Our Patients Say: Stories of Hope and Recovery
Hear directly from those who have walked the path to recovery. Our patients’ stories highlight the compassionate care, effective programs, and life-changing support they’ve experienced. Let their journeys inspire you as you take your first steps toward healing.


